Our vision at
The BioMAD Lab
The BioMAD Lab is focused on accelerating this paradigm shift from traditional approaches to precision medicine-driven approaches in healthcare by developing cutting-edge biosensing solutions and advanced materials designed to make high-quality healthcare accessible for all. Specifically, we focus on innovations in materials design and engineering while harnessing the power of multiplexed biomarker panels to enable the next-generation of accurate and minimally-invasive healthcare solutions for diagnostics and therapeutic applications. Our future outlook will involve integrating machine learning and artificial intelligence within our solutions - both at the design and analysis stages - to empower even more informed and precise clinical decisions based on a patient's unique biomarkers. My research approach and the transformative technologies of the BioMAD lab will enable us to achieve the ultimate aim of precision medicine, being ‘right patient, right time, right treatment.’
Aligning BioMAD’s Mission with Saudi’s Vision 2030
The BioMAD Lab's mission is to revolutionize healthcare through ground-breaking advancements in materials science and bioengineering. We leverage our unique expertise in xeno nucleic acids, biomaterials, nanomaterials, and microtechnologies to design and develop next-generation biosensing tools for early disease detection, personalized medicine, and ultimately, improved patient outcomes.
Our research efforts directly address the goals outlined in Saudi Vision 2030, particularly in the area of healthcare transformation. Our research also directly aligns with the University's research pillars and Saudi Arabia’s national priorities as defined by the Research Development and Innovation Authority (RDIA). By developing minimally invasive, cost-effective, and patient-centric diagnostic solutions, we aim to make high-quality healthcare accessible to all Saudi citizens. By developing rapid, accessible, liquid biopsy-based tests for diseases such as cancer, I'm working towards a future where high-quality healthcare is within reach for all. This work not only advances science but also charts a course towards more accurate, cost-effective, and minimally invasive diagnostics—crucial elements of personalized medicine. We pioneered the first Saudi PNA synthesis workflow, the first Saudi system to fabricate graphically-encoded microparticles for multiplexed biosensing, and the first Saudi lab to exploit solid-state nanopores for ultrasensitive biosensor development.